Anti LAG3/PD-1 bispecific antibody (Fontacea )

LAG3/PD-1双特异性抗体（方坦思）

Report date: 2021/12/08 14:19:50

Base Information

Drug NameAnti LAG3/PD-1 bispecific antibody (Fontacea )
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionLymphocyte activation gene 3 protein inhibitorsProgrammed cell death protein 1 blockers
TargetsLymphocyte activation gene 3 proteinProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Fontacea Pharmaceutical Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Fontacea Pharmaceutical Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A